Companies Cryptocurrencies
Qualigen Therapeutics Inc
Qualigen Therapeutics Inc
Exchange: NasdaqGS
IPO Date: 24/06/2015
CEO: Mr. Michael S. Poirier
Biotechnology Healthcare 🔗
  • QLGN
  • 0.5315
  • 18759558
    market cap
  • -0.00060004
If you bought

shares of Qualigen Therapeutics Inc (QLGN) on
You would have made
Old Price $12 Current Price $12

Qualigen Therapeutics, Inc., formerly Ritter Pharmaceuticals, Inc., is a biotechnology company. The Company is focused on the development and commercialization of therapeutic products for the treatment of cancer and infectious diseases, as well as development of its FastPack diagnostic platform. Its pipeline includes AS1411, Aptamer Linked Anti Nucleolin (ALAN), Aptamer Linked Anti Nucleolin – Contrast Enhancement (ALAN-CE), Aptamer Linked Anti Nucleolin – Radiation Enhancement (ALAN-RE), Selective Target Antigen Removal System (STARS) and RAS-F. The FastPack System is an immunoassay testing system, which consists of the FastPack Analyzer and the FastPack test pouch, a single-use, disposable, foil packet which includes the FastPack reagent chemistry. The Company’s subsidiary is Qualigen, Inc.

Address: 1880 Century Park E Ste 1000 Los Angeles CALIFORNIA 92011

Stay updated.